Asia-Pacific Americas Africa Europe Middle East

MYLAN PHARMACEUTICALS PVT LTD

Company Profile:

MYLAN PHARMACEUTICALS PVT LTD Company Introduction

MYLAN PHARMACEUTICALS PVT LTD is primarily a manufacturing entity (factory).

Mylan Pharmaceuticals Private Limited is the Indian subsidiary of what was formerly Mylan N.V., a global pharmaceutical company. Following its merger with Upjohn, it is now part of Viatris Inc. In India, MYLAN PHARMACEUTICALS PVT LTD plays a significant role in the parent company's global operations, focusing on the research, development, and large-scale manufacturing of generic and specialty pharmaceutical products, as well as active pharmaceutical ingredients (APIs). Its facilities produce a wide range of medications, including those for HIV/AIDS, cardiovascular diseases, oncology, and other therapeutic areas, serving both domestic and international markets. The company integrates manufacturing, quality control, and supply chain management within its operations.

Enterprise Products

Mylan Pharmaceuticals Pvt. Ltd. (India) produces and/or markets a wide range of pharmaceutical products, including:

* Active Pharmaceutical Ingredients (APIs)

* Generic Medicines

* Branded Generics

* Antiretrovirals (ARVs)

* Women's Healthcare Products

* Respiratory Products

* Injectables

* Oncology Products

* Cardiovascular Products

* Anti-infectives

* Central Nervous System (CNS) Products

* Gastrointestinal Products

* Pain Management Products

* Allergy and Immunology Products

* Biosimilars (in some markets, may be branded differently)

Business Registration Information:

Manager:

Sanjeev Sethi

Phone:

+91 22 61533000

E-mail:

pv.india@viatris.com

Official Website:
Address:

The Capital, C-43, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400051, Maharashtra, India

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.